Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of THC and CBD on Episodic Memory
NCT02291562Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Jul 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dronabinol and cannabidiol in No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity (3 arms), sponsored by Central Institute of Mental Health. Primary endpoint: Blood Oxygen Level Dependent responses. Started Jul 2014; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.
Beyond the preview
Go deeper on NCT02291562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291562.